유동성 지혈제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Flowable Hemostats Market size is expected to reach USD 1.38 Billion in 2034 from USD 0.83 Billion (2025) growing at a CAGR of 5.86% during 2026-2034.

The flowable hemostats market is growing steadily due to increasing surgical procedures and rising trauma cases worldwide. Surgeons rely on flowable hemostats for rapid bleeding control in complex surgeries. The growing prevalence of cardiovascular diseases and orthopedic conditions requiring surgical intervention is boosting product demand across hospitals and surgical centers.

Drivers include technological advancements in biocompatible materials, improved product efficacy, and expanding healthcare infrastructure in developing regions. Minimally invasive surgeries and outpatient procedures are increasing the adoption of advanced hemostatic agents. Strong research and development activities are also contributing to product innovation and market competitiveness.

Future prospects remain strong as healthcare systems prioritize patient safety and reduced surgical complications. Increasing investments in trauma care and emergency response services will further support demand. With continuous product innovation and rising surgical volumes globally, the flowable hemostats market is expected to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Origin

• Bovine
• Porcine

By Application

• General Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Gynecological Surgery
• Neurosurgery
• Reconstructive Surgery
• Other

By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCS)
• Other

COMPANIES PROFILED

• 3D Matrix Medical Technology, Aegis Lifesciences Private Limited, Baxter International Inc, CR Bard Inc Becton Dickinson Company, Ethicon Inc Johnson Johnson, Ferrosan Medical Devices AS, Integra LifeSciences Corporation, Medcura Inc, Pfizer Inc, Teleflex Incorporated
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FLOWABLE HEMOSTATS MARKET: BY ORIGIN 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Origin
• 4.2. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Porcine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FLOWABLE HEMOSTATS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Gynecological Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Reconstructive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FLOWABLE HEMOSTATS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers (ASCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FLOWABLE HEMOSTATS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Origin
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Origin
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Origin
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Origin
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Origin
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FLOWABLE HEMOSTATS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 3D Matrix Medical Technology
  • 9.2.2 Aegis Lifesciences Private Limited
  • 9.2.3 Baxter International Inc
  • 9.2.4 CR Bard Inc. (Becton Dickinson Company)
  • 9.2.5 Ethicon Inc. (Johnson & Johnson)
  • 9.2.6 Ferrosan Medical Devices A/S
  • 9.2.7 Integra LifeSciences Corporation
  • 9.2.8 Medcura Inc
  • 9.2.9 Pfizer Inc
  • 9.2.10 Teleflex Incorporated